RadNet, Inc. (RDNT) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2026. RadNet, Inc. operates as a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States, reporting through two segments: Imaging Centers and Digital Health. As of June 30, 2026, the company operated 442 centers directly or through joint ventures across 11 states. The Digital Health segment, branded as DeepHealth, focuses on AI-driven diagnostic solutions and workflow optimization.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2026 | Six Months Ended June 30, 2026 |
|---|---|---|
| Total Service Revenue | $622.7 million | $1,198.4 million |
| Net Income (Loss) Attributable to RadNet | $7.5 million | $(25.9) million |
| Adjusted EBITDA (Total Company) | $99.7 million | $162.9 million |
| Operating Cash Flow (Six Months) | $173.1 million | |
| Cash and Cash Equivalents | $726.3 million (as of June 30, 2026) | |
| Total Debt Obligations | $1,338.2 million (including finance leases) | |
| Available Liquidity (Revolvers) | $323.4 million ($273.4M Barclays + $50.0M Truist) |
Material Changes vs. Prior Period
- Revenue Growth: Total service revenue increased 25.0% year-over-year for the quarter and 23.6% for the six-month period. This was driven by a 23.5% increase in Imaging Center revenue and a 56.5% surge in Digital Health revenue.
- Profitability: While the Imaging Center segment remained profitable with a segment profit of $92.8 million (Q2), the Digital Health segment reported a net loss of $11.5 million (Q2) due to heavy investment in R&D and integration costs. Consolidated net loss attributable to common stockholders for the six months was $25.9 million, compared to a loss of $23.5 million in the prior year period.
- Acquisitions: Significant M&A activity occurred, including the acquisition of Gleamer SAS (Digital Health) for approximately $264.1 million and several Imaging Center assets for $86.0 million. These activities contributed to a $283.7 million increase in cash used for investing activities.
- Debt Structure: On June 10, 2026, the company executed an incremental amendment to its Barclays Credit Agreement, securing an additional $250.0 million in term loan borrowings and reducing the interest rate margin by 0.25%.
Guidance, Outlook, and Risks
- Digital Health Outlook: Management expects the Digital Health segment to continue operating at a net loss in the near term as it integrates recent acquisitions (iCAD, See-Mode, CIMAR, and Gleamer) and scales its AI platforms. Annual Recurring Revenue (ARR) for the segment reached $105.5 million, up from $53.5 million the prior year.
- Operational Efficiency: The company cites improved labor efficiency and workflow optimization from DeepHealth technology as key drivers for controlling salary expense growth relative to revenue growth in the Imaging Centers segment.
- Risks and Contingencies:
- Contingent Consideration: The company has significant contingent consideration liabilities related to recent acquisitions (See-Mode, Kolb Radiology, CIMAR, Gleamer), totaling approximately $22.8 million as of June 30, 2026, which are subject to fair value remeasurement.
- Interest Rate Sensitivity: With approximately $1.3 billion in variable-rate debt, a 1% increase in SOFR would increase annual interest expense by approximately $13.3 million.
- Regulatory: The company is monitoring the impact of the "One Big Beautiful Bill Act" (OBBBA) and global minimum tax rules (Pillar Two), though no material impact is currently expected for 2026.
Investor Verification Checklist
- Debt Covenants: Verify compliance with leverage ratios under the Barclays and Truist credit facilities following the $250M incremental borrowing.
- Acquisition Integration: Monitor the integration progress and revenue contribution of the Gleamer SAS acquisition, specifically the deployment timeline across RadNet centers.
- Digital Health Burn Rate: Track the trajectory of Digital Health operating losses against the growth in Annual Recurring Revenue (ARR) to assess path to profitability.
- Contingent Liabilities: Review the probability assumptions used for the fair value of contingent consideration, particularly for the See-Mode and Gleamer milestones.
- Same-Center Growth: Validate the sustainability of the 11.1% same-center revenue growth in the Imaging segment, distinguishing between volume growth and reimbursement rate changes.